MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%
Sector Heatmap
Technology+1.05%
Financials+0.11%
Healthcare-1.32%
Consumer Cycl-0.03%
Consumer Staples-0.33%
Energy+1.95%
Industrials+0.99%
Materials-0.33%
Real Estate-0.56%
Utilities+0.61%
Comm Services-0.93%
ALNY — Alnylam Pharmaceuticals, Inc.
NasdaqAlnylam Pharmaceuticals, Inc.
$231.04
-15.70(-6.36%)
- O
- 248.21
- H
- 251.71
- L
- 230.06
- V
- 2.01M
⏱️ End-of-day dataAs of Oct 1, 2026
ALNY — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash And Cash Equivalents | $171.08M | $165.72M | $149.02M | $111.37M | $101.97M | $96.64M |
| Other Short Term Investments | $129.84M | $125.12M | $123.44M | $174.39M | $161.26M | $172.81M |
| Accounts Receivable | $88.40M | $77.76M | $96.48M | $56.71M | $41.80M | $40.53M |
| Inventory | $84.03M | $82.72M | $75.38M | $71.69M | $65.58M | $78.51M |
| Other Current Assets | $24.21M | $28.19M | $18.80M | $14.73M | $15.24M | $11.70M |
| Total Current Assets | $421.93M | $405.07M | $395.28M | $364.37M | $326.83M | $329.53M |
| Properties | $70.76M | $38.48M | $69.31M | $69.22M | $69.59M | $36.22M |
| Other Non Current Assets | $20.27M | $20.76M | $20.57M | $23.01M | $24.96M | $25.08M |
| Total Non Current Assets | $91.02M | $91.57M | $89.89M | $92.23M | $94.56M | $94.47M |
| Total Assets | $512.95M | $496.63M | $485.17M | $456.60M | $421.38M | $424.00M |
| Accounts Payable | $12.66M | $11.57M | $11.76M | $10.24M | $97.40M | $88.42M |
| Accrued Expenses | $94.65M | $82.30M | $115.36M | $91.90M | $70.42M | $67.31M |
| Short Term Debt | $45.66M | $45.52M | $44.76M | $46.10M | $46.01M | $41.89M |
| Deferred Revenue | $3.21M | $4.84M | $2.54M | $15.08M | $28.16M | $55.48M |
| Other Current Liabilities | $22.75M | $22.01M | $23.69M | $21.83M | $19.99M | $11.30M |
| Total Current Liabilities | $134.95M | $146.63M | $155.55M | $130.08M | $107.56M | $118.63M |
| Long Term Debt | $122.74M | $123.29M | $126.37M | $125.10M | $125.56M | $125.42M |
| Other Non Current Liabilities | $147.73M | $147.79M | $135.89M | $135.61M | $134.47M | $173.25M |
| Total Non Current Liabilities | $270.47M | $271.08M | $306.23M | $301.46M | $302.28M | $298.66M |
| Total Liabilities | $405.42M | $417.72M | $461.78M | $431.54M | $409.84M | $417.29M |
| Common Stock | $1.33M | $1.32M | $1.32M | $1.31M | $1.30M | $1.29M |
| Retained Earnings | $-649.65M | $-670.25M | $-716.04M | $-741.15M | $-734.52M | $-728.77M |
| Other Shareholders Equity | $-24.89M | $-20.10M | $-21.77M | $-29.95M | $-37.52M | $-34.52M |
| Total Shareholders Equity | $107.54M | $78.92M | $23.39M | $25.06M | $11.54M | $67.09M |
| Additional Paid In Capital | $759.55M | $751.05M | $741.48M | $769.07M | $749.69M | $738.81M |
| Land And Improvements | N/A | $9.08M | N/A | N/A | N/A | $9.08M |
| Machinery Furniture Equipment | N/A | $57.24M | N/A | N/A | N/A | $54.18M |
| Construction In Progress | N/A | $40.95M | N/A | N/A | N/A | $7.67M |
| Leases | N/A | $24.11M | N/A | N/A | N/A | $23.67M |
| Accumulated Depreciation | N/A | $-32.27M | N/A | N/A | N/A | $-27.04M |
| Pensions | N/A | $25.72M | N/A | N/A | N/A | $21.44M |
| Derivative Product Liabilities | N/A | 0.00 | $43.97M | $40.75M | $42.24M | N/A |